Review of botulinum toxin type A and its clinical applications in migraine headache

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 10, 2001, Pages 1649-1654

  Silberstein, S D ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Botox ; Botulinum toxin type A; Clincal efficacy; Headache; Migraine; Tolerability

Indexed keywords

AMINOGLYCOSIDE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; BOTULINUM TOXIN A; ERGOT DERIVATIVE; MYCOBLOC; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; PROPRANOLOL; TIMOLOL; VALPROATE SEMISODIUM;

ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE RELAXATION; MUSCLE SPINDLE; NAUSEA; NONHUMAN; PATIENT INFORMATION; PREDICTION; PREVENTIVE MEDICINE; SIDE EFFECT;

BOTULINUM TOXIN TYPE A; HUMANS; MIGRAINE DISORDERS; NEUROMUSCULAR AGENTS;

EID: 0034758711     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.10.1649     Document Type: Article

References (43)

1. Prevalence of migraine in the United States
2. Diagnosis and treatment of migraine
3. Classification and epidemiology of headache
4. Burden of migraine in the United States
5. Advances in pharmacotherapy of migraine
6. Symptomatic and prophylactic treatment of migraine: A critical reappraisal
7. Brain stem activation in spontaneous human migraine attacks
8. How to pick optimal acute treatment for migraine headache
9. Practice parameter: Evidence-based guidelines for migraine headache
10. Stratified care is a more effective migraine treatment strategy than stepped care: Results of a randomised clinical trial
11. Medical consultation for migraine: Results from the American migraine Study
12. The current use of botulinum toxin
13. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
14. Resolution of chronic tension headache after botulinum toxin treatment of idiopathic blepharospasm
15. Treatment of tension-type headache by local injection of botulinum toxin
16. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension
17. Improvement of tension-type headache when treating wrinkles with botulinum toxin A injections
18. Treatment of tension-type headache with botulinum toxin: A pilot study
19. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A
20. Treatment of tension-type headache with botulinum toxin: 1-year follow-up
21. Botulinum A toxin for wrinkles: Release from tension headache
22. Botulinum toxin injections for cervicogenic headache
23. Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study
24. Botulinum toxin type A in the treatment of headache syndromes: A clinical report on 79 patients
25. Botulinum toxin type A (BOTOX) for the treatment of migraine headaches: An open-label study
26. Botox for migraine: Double-blind, placebo-controlled, region-specific evaluation
27. Botulinum toxin A is an effective prophylactic therapy for migraines
28. Botulinum toxin type A as a migraine preventive treatment
29. How botulinum and tetanus neurotoxins block neurotransmitter release
30. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
31. Physiological effects produced by botulinum toxin treatment of the upper limb dystonia. Changes in reciprocal inhibition between forearm muscles
32. The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injection site
33. Modification of cervical dystonia by selective sensory stimulation
34. Clinical and polymyographic investigation of spasmodic torticollis
35. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-a injection
36. Botulinum A toxin effects on rat jaw muscle spindles
37. The development of BOTOX-its history and pharmacology
38. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex
39. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles
40. Botulinum toxin type a (BTX-a) reduces inflammatory pain in the rat formalin model
41. Botulinum antibodies in dystonic patients treated with type A botulinum toxin: Frequency and significance
42. Botulinum toxin therapy, immunologic resistance and problems with available material
43. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia